Verdence Capital Advisors LLC Buys 239 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

by · The Markets Daily

Verdence Capital Advisors LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 16,957 shares of the healthcare conglomerate’s stock after purchasing an additional 239 shares during the period. UnitedHealth Group makes up about 0.8% of Verdence Capital Advisors LLC’s portfolio, making the stock its 21st biggest position. Verdence Capital Advisors LLC’s holdings in UnitedHealth Group were worth $9,915,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in UnitedHealth Group by 0.6% in the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock valued at $41,755,280,000 after acquiring an additional 544,740 shares during the period. Price T Rowe Associates Inc. MD grew its stake in UnitedHealth Group by 0.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after acquiring an additional 94,641 shares during the period. Bank of New York Mellon Corp raised its position in UnitedHealth Group by 0.4% during the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock worth $4,094,247,000 after acquiring an additional 35,533 shares during the period. International Assets Investment Management LLC increased its stake in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after buying an additional 5,290,025 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.8 %

Shares of UNH stock opened at $616.33 on Friday. The firm has a fifty day moving average of $581.93 and a 200-day moving average of $545.03. The company has a market capitalization of $567.20 billion, a price-to-earnings ratio of 40.15, a P/E/G ratio of 1.75 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $619.80.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the previous year, the firm posted $6.56 EPS. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.36%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on UNH. Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Truist Financial reiterated a “buy” rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Stephens decreased their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Finally, Bank of America reduced their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

View Our Latest Analysis on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles